Autoimmune pancreatitis (diagnostic criteria)

There are several diagnostic criteria for autoimmune pancreatitis (AIP), with some overlap and contradictions.

Asian 2008 AIP diagnostic criteria

• both criteria I to be fulfilled
• one criteria II
• consistent histology

The criteria are ¹:

• criteria I:imaging
  • enlargement of the gland (may be diffuse/segmental/focal) +/- hypo-attenuating rim (halo)
  • pancreatic duct narrowing (may be diffuse/segmental/focal) +/- stenosis of the common bile duct
• criteria II: serology
  • elevated serum IgG or IgG4
  • detectable autoantibodies (ANA, RF)
• criteria III: histopathology
  • lymphoplasmacytic infiltration (IgG4 positive) with fibrosis 

Mayo Clinic HISORt criteria (2007)

AIP should be suspected in patients with obstructive jaundice, pancreatic mass/enlargement, or pancreatitis, AND one or more of five cardinal features of AIP in ²: 

• histology
• imaging
• serology
• other organ involvement
• response to steroid therapy 

summarized in the mnemonic HISORt.

Typical histological features include lymphoplasmacytic infiltrate with storiform fibrosis; classical imaging features of AIP; elevated IgG4.

Unlike the Asian criteria, the Mayo Clinic criteria takes account of possible other organ involvement accompanying AIP in the setting of IgG4-related sclerosing disease, and also of the response to steroid therapy following which normalisation of imaging and histological findings is expected.

International Consensus Diagnostic Criteria (ICDC) for AIP

In 2010, during the 14th Congress of the International Association of Pancreatology, criteria were proposed as a consensus of the working group ³. These are the same as the five Mayo Clinic ² as above features with response to steroids being optional. Levels 1 and 2 have been introduced based on the diagnostic reliability of each feature.